Communication device and communication method
US-2018013596-A1 · Jan 11, 2018 · US
US10537246B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10537246-B2 |
| Application number | US-201815890509-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 7, 2018 |
| Priority date | Feb 8, 2017 |
| Publication date | Jan 21, 2020 |
| Grant date | Jan 21, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medical system and method of communicating between a telemetry controller and medical devices is provided. Coupling coefficients between a primary coil of the telemetry controller and secondary coils of the medical devices differ from each other. A primary carrier signal is applied to the primary coil, thereby respectively inducing secondary carrier signals on the secondary coils. An amplitude of the secondary carrier signal is measured on each of the secondary coils. The envelope of each secondary carrier signal is modulated in accordance with data, thereby inducing modulation of the envelope of the primary carrier signal for the implanted medical devices. The secondary carrier signal envelopes are modulated based on the measured amplitudes of the respective secondary carrier signals.
Opening claim text (preview).
What is claimed is: 1. A medical system, comprising: a telemetry controller comprising: a primary coil; a coil driver configured for applying a primary carrier signal having an envelope to the primary coil, the primary carrier signal envelope capable of being modulated; and a demodulator configured for amplitude demodulating the modulated primary carrier signal envelope to acquire data; and a plurality of implantable medical devices, each of which comprising: a secondary coil on which a secondary carrier signal having an envelope may be induced in response to the application of the primary carrier signal on the primary coil; an amplitude detector configured for measuring an amplitude of the secondary carrier signal; a modulator configured for amplitude modulating the secondary carrier signal envelope in accordance with data, thereby inducing an amplitude modulation of the primary carrier signal envelope on the primary coil, wherein the modulators of the implantable medical devices are configured for modulating their respective secondary carrier signal envelopes based on the measured amplitude of their respective secondary carrier signals, such that a variation of a peak-to-peak amplitude of the induced amplitude modulations of the primary carrier signal envelope between the implantable medical devices is decreased. 2. The medical system of claim 1 , wherein the telemetry controller is an external telemetry controller. 3. The medical system of claim 1 , wherein the measured amplitude of their respective secondary carrier signals comprises a peak amplitude of their respective secondary carrier signals. 4. The medical system of claim 1 , wherein the demodulator is configured for amplitude demodulating the modulated primary carrier signal envelope by: detecting the induced amplitude modulations of the primary carrier signal envelope; and comparing the detected induced amplitude modulations of the primary carrier signal envelope to a threshold level. 5. The medical system of claim 4 , wherein an amplitude of the threshold level is between a minimum and a maximum of the modulated primary carrier signal envelope. 6. The medical system of claim 5 , wherein the amplitude of the threshold level is centered between the minimum and the maximum of the modulated primary carrier signal envelope. 7. The medical system of claim 1 , wherein the induced amplitude modulations of the primary carrier signal envelope are substantially uniform for the implantable medical devices. 8. The medical system of claim 7 , wherein a variation in the induced amplitude modulations of the primary carrier signal envelope between the implantable medical devices is less than 50%. 9. The medical system of claim 7 , wherein a variation in the induced amplitude modulations of the primary carrier signal envelope between the implantable medical devices is less than 20%. 10. The implantable medical system of claim 1 , wherein the modulators are configured for modulating the envelope of their respective secondary carrier signals, such that modulation magnitudes of the modulated envelope of their respective secondary carrier signals vary in an inversely varying relationship with coupling coefficients between their respective secondary coils and the primary coil. 11. The medical system of claim 1 , wherein the amplitude detector of each of the implantable medical devices is configured for measuring the amplitude of their respective secondary carrier signals on their respective secondary coils by measuring a voltage across their respective secondary coils, and the modulator of each of the implantable medical devices is configured for amplitude modulating the envelope of their respective secondary carrier signals by modifying a load current associated with their respective secondary coils as a function of the measured voltage. 12. The medical system of claim 1 , wherein each of the implantable medical devices further comprises a rectifier configured for rectifying and regulating their respective secondary carrier signals for powering circuitry within their respective implantable medical devices. 13. The implantable medical system of claim 1 , wherein the modulators are configured for load modulating their respective secondary carrier signal envelopes. 14. The medical system of claim 1 , wherein the data is physiological data of a patient, wherein each of the implantable medical devices further comprises at least one sensor configured for acquiring the physiological data from the patient. 15. The medical system of claim 1 , wherein the data is operational status data of each of the implantable medical devices. 16. A method of communicating between a telemetry controller and a plurality of medical devices implanted within a patient, the telemetry controller having a primary coil and each of the medical devices has a secondary coil, wherein coupling coefficients between the primary coil and the secondary coils differ from each other, the method comprising: applying a primary carrier signal having an envelope to the primary coil, thereby respectively inducing a secondary carrier signal having an envelope on each of the secondary coils; generating data by each of the implanted medical devices; measuring an amplitude of the secondary carrier signal on each of the secondary coils; sequentially amplitude modulating each of the secondary carrier signal envelopes in accordance with the data generated by the respective implanted medical devices, thereby inducing amplitude modulations of the primary carrier signal envelope on the primary coil for the implanted medical devices, wherein the secondary carrier signal envelopes are modulated based on the measured amplitudes of the respective secondary carrier signals, such that a variation of a peak-to-peak amplitude of the induced amplitude modulations of the primary carrier signal envelope between the implanted medical devices is decreased; and amplitude demodulating the induced amplitude modulations of the primary carrier signal envelope to acquire the data from the implanted medical devices. 17. The method of claim 16 , wherein the telemetry controller is external to the patient. 18. The method of claim 16 , wherein the measured amplitudes of the secondary carrier signals comprise peak amplitudes of the secondary carrier signals. 19. The method of claim 16 , wherein amplitude demodulating the induced amplitude modulations of the primary carrier signal envelope comprises: detecting the induced amplitude modulations of the primary carrier signal envelope; and comparing the detected induced amplitude modulations of the primary carrier signal envelope to a threshold level. 20. The method of claim 19 , wherein an amplitude of the threshold level is centered between a minimum and a maximum of the induced amplitude modulations of the primary carrier signal envelope. 21. The method of claim 16 , wherein the induced amplitude modulations of the primary carrier signal envelope are substantially uniform for the implanted medical devices. 22. The method of claim 21 , wherein a variation in the induced amplitude modulations of the primary carrier signal envelope between the implanted medical devices is less than 50%. 23. The method of claim 21 , wherein a variation in the induced amplitude modulations of the primary carrier signal envelope between the implanted medical devices is less than 20%. 24. The method of claim 16 , wherein each of the se
Frequency-modulated carrier systems, i.e. using frequency-shift keying (H04L27/32 takes precedence) · CPC title
Amplitude-modulated carrier systems, e.g. using on-off keying; Single sideband or vestigial sideband modulation (H04L27/32 takes precedence) · CPC title
characterised by communication with experts in remote locations using a network · CPC title
Amplitude modulation · CPC title
Communication to several implantable medical devices within one patient · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.